Patents Assigned to E-Therapeutics PLC
  • Patent number: 12338438
    Abstract: The present invention relates to novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: June 24, 2025
    Assignee: E-Therapeutics PLC
    Inventors: Ahmad Ali Mortazavi, Viviana Mannella, Muthusamy Jayaraman
  • Publication number: 20210238139
    Abstract: There are described compounds of formula (I): (I) and their use as a medicament in the treatment of diseases associated with the abnormal or elevated catabolism of tryptophan, such as, cancer, immunosuppression, viral infection, depression, a neurodegenerative disorder, trauma, age-related cataracts, organ transplant rejection, or an autoimmune disorder in a patient.
    Type: Application
    Filed: May 31, 2019
    Publication date: August 5, 2021
    Applicant: E-Therapeutics PLC
    Inventors: Tanja Poljak, Marina Modric, Srinivasamurthy Vadlamudi, Colin Stubberfield
  • Publication number: 20200055847
    Abstract: There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD).
    Type: Application
    Filed: October 25, 2017
    Publication date: February 20, 2020
    Applicant: e-Therapeutics PLC
    Inventors: Maja ROSCIC, Filip KOLUNDZIC, Dinko ZIHER, Tanja POLJAK, Srinivasamurthy VADLAMUDI, Colin STUBBERFIELD
  • Publication number: 20180354876
    Abstract: There is described a method of preparing a compound of formula I, and optical isomers thereof; in which R1 is hydrogen or a protecting group; said method comprising oxidising verbenone and optical isomers thereof.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 13, 2018
    Applicant: e-Therapeutics plc
    Inventors: Vijaya Bhasker Gondi, James Thomson Loch, III, Nicholas John Holman, Steven James Collier
  • Publication number: 20180042891
    Abstract: There is described a therapeutic agent capable of directly or indirectly having an effect on the proteins N-methyl-D-aspartate (NMDA), Cyclooxygenase-2 (COX-2), Tumour Necrosis factor alpha (TNF-a), Nuclear factor-kappa B (NF?B), Cyclin-dependent kinases, e.g. CDK2/A and CDK5/p25, Histone acetyltransferase (HAT) and Farnesyltransferase, simultaneously, sequentially or separately. There is especially described dexanabinol, or a derivative thereof, as the therapeutic agent.
    Type: Application
    Filed: October 3, 2017
    Publication date: February 15, 2018
    Applicant: e-Therapeutics plc
    Inventors: Malcolm Philip Young, Philip McKeown
  • Patent number: 9183287
    Abstract: An information processing apparatus (5) is provided including: a lexicon generation module (22) operable to identify strings of characters present in a set of social media posts (50); a network data generation module (24) operable to generate network data in which posts are associated with nodes and link data (53) link nodes corresponding to posts which contain similar sets of strings of characters; and a network analysis module (26) operable to process network data generated by the network data generation module (24) to determine one or more metric values for each of the nodes wherein the metric values are determined based on the patterns of connectivity defined by the link data (53). The generated metric values are then utilized to select one or more posts (55) as posts representative of the set of media posts.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: November 10, 2015
    Assignee: E-Therapeutics PLC
    Inventor: Malcolm P. Young
  • Patent number: 9002658
    Abstract: A computer system (2) is provided which is arranged to receive network data (1) identifying nodes and links between nodes. The computer system (2) processes the input network data (1) to utilise the network topology to identify nodes and links having high importance for network integrity. A report (4) identify the critical components can then be output.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: April 7, 2015
    Assignee: E-Therapeutics PLC
    Inventors: Malcolm P. Young, Peter E. Andras, Mark A. O'Neill
  • Patent number: 8862586
    Abstract: An information processing apparatus (5) is provided comprising: a lexicon generation module (22) operable to process a set of documents (1) to identify key words (2) present in the documents; a link generation module (24) operable to generate network data (3) linking documents which share the same or semantically related key words identified by the lexicon generation module; and a network analysis module (26) operable to associate documents with metric values based upon the patterns of connectivity of the network data generated by the link generation module. The metric values associated with documents in the set can be utilized to select documents or groups of associated documents for further processing or indexing.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: October 14, 2014
    Assignee: E-Therapeutics PLC
    Inventor: Malcolm P. Young
  • Patent number: 8614179
    Abstract: There is described a composition comprising a therapeutically active imidazole, and derivatives thereof, and an agent active on a bacterial cell surface selected from the group consisting of one or more of colistin, nisin, D-cycloserine, fosfomycin, fosfomycin trometamol, fosfomycin disodium and polymixin B, and derivatives thereof.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: December 24, 2013
    Assignee: E-Therapeutics PLC
    Inventors: Malcolm Philip Young, Catherine Mary Thomas
  • Publication number: 20130296437
    Abstract: There is described a method of treatment of a patient suffering from depression, said method comprising the administration of a sub-analgesic amount of tramadol, or a salt thereof.
    Type: Application
    Filed: March 5, 2013
    Publication date: November 7, 2013
    Applicant: e-Therapeutics plc
    Inventors: Malcolm Philip Young, Philip McKeown
  • Patent number: 8301391
    Abstract: A computer system (2) is provided which is arranged to receive network data (1) identifying nodes and links between nodes. The computer system (2) processes the input network data (1) to utilize the network topology to identify nodes and links having high importance for network integrity. A report (4) identify the critical components can then be output.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: October 30, 2012
    Assignee: E-Therapeutics PLC
    Inventors: Malcolm P. Young, Peter E. Andras, Mark A. O'Neill
  • Patent number: 7990878
    Abstract: A computer system (2) is provided which is arranged to receive network data (1) identifying nodes and links between nodes. The computer system (2) processes the input network data (1) to utilise the network topology to identify nodes and links having high importance for network integrity. A report (4) identify the critical components can then be output.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: August 2, 2011
    Assignee: E-Therapeutics PLC
    Inventors: Malcolm P. Young, Peter E. Andras, Mark A. O'Neill
  • Patent number: 7768942
    Abstract: A computer system (2) is provided which is arranged to receive network data (1) identifying nodes and links between nodes. The computer system (2) processes the input network data (1) to utilise the network topology to identify nodes and links having high importance for network integrity. A report (4) identifying the critical components can then be output.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: August 3, 2010
    Assignee: E-Therapeutics PLC
    Inventors: Malcolm P. Young, Peter E. Andras, Mark A. O'Neill